Search

everythinglearnresearchcommunity

for

Search:↓

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Nilotinib can cause keratosis pilaris, a skin condition.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Sweet syndrome can be the only sign of hairy cell leukemia relapse.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Wavy sinus hairs in cats are linked to feline leukemia virus infection.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Phthirusa pyrifolia extract may lower testosterone and harm male rat reproduction without damaging the liver or kidneys.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.